Acerus Pharmaceuticals (OTCMKTS:TRLPF) Stock Passes Above 200-Day Moving Average – Here’s Why

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPFGet Free Report)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.22 and traded as high as $0.22. Acerus Pharmaceuticals shares last traded at $0.22, with a volume of 0 shares changing hands.

Acerus Pharmaceuticals Stock Performance

The company has a quick ratio of 0.90, a current ratio of 1.35 and a debt-to-equity ratio of 0.64. The firm’s 50 day moving average is $0.22 and its two-hundred day moving average is $0.22. The stock has a market cap of $56.90 million, a price-to-earnings ratio of -2.75 and a beta of 2.60.

Acerus Pharmaceuticals Company Profile

(Get Free Report)

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

Featured Articles

Receive News & Ratings for Acerus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acerus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.